Attorney Jonathan Hyman and Andrew Merickel were quoted in “Why Patent Cannabis? For Markets, Mostly,” which was published in Forbes.
Excerpt: “Patents “generate interest in the company, and are something investors would look at,” said Jonathan Hyman.
“Having this patent, that they can wave around and say, ‘Hey, we’ve got coverage on it, and it’s the best variety [of CBD rich hemp] that you’re going to get,” said Andrew Merickel.
